This week marks a victory for patients with LEMS and American taxpayers, and a blow to the greed of Big Pharma, suffering patients used to receive life-saving medication for free from Jacobus Pharmaceuticals -- until a competitor, Catalyst, bought the rights to the drug, received market exclusivity, and started charging $ 375,000 a year to those in desperate need.
This page is about the voters of this citizen quote.
We're doing our best to make sure our content is useful, accurate and safe. If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Share your thoughts on this citizen quote voters with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In